AAI
SPRY icon

American Assets Inc’s ARS Pharmaceuticals SPRY Stock Holding History

American Assets Inc’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
125,000
+118,000
+1,686% +$1.02M 0.3% 8
2026
Q1 		$1.71M Sell
7,000
-48,000
-87% -$460K 0.57% 6
2025
Q4 		$641K Hold
55,000
– – 0.2% 18
2025
Q3 		$553K Buy
+55,000
New +$789K 0.18% 23

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

American Assets Inc's SPRY Position: Q2 2026 in Review

American Assets Inc increased its ARS Pharmaceuticals (SPRY) stake by 1,686% in Q2 2026, buying an estimated $1.02M and bringing the position to 125,000 shares worth $1M. The position accounts for 0.3% of the portfolio, ranked #8.

American Assets Inc first reported a position in SPRY in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.71M in Q1 2026. 209 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • American Assets Inc held 125,000 shares of ARS Pharmaceuticals worth $1M as of Q2 2026.
  • American Assets Inc bought 118,000 ARS Pharmaceuticals shares in Q2 2026, an estimated $1.02M.
  • ARS Pharmaceuticals made up 0.3% of American Assets Inc's portfolio in Q2 2026, its #8 holding.
  • American Assets Inc first reported a position in ARS Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • American Assets Inc's ARS Pharmaceuticals position peaked at $1.71M in Q1 2026.
  • 209 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on American Assets Inc's 13F filing for Q2 2026, filed 5 Aug 2026.